InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Ray Amrit, 董事. Insider active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 7 disclosures have been logged. Activity tracked since 19 April 2022. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ray Amrit is Administrateur at Ultragenyx Pharmaceutical Inc. and Fortrea Holdings Inc. The record shows 7 filings in total, all in the sampled set, from 2022-04-22 to 2025-05-19, with transaction nature listed as Attribution and buy and sell amounts of EUR 0 in the recent filings observed.